entertainment -WSS

entertainment

author：fashion 2025-09-28 23:47:52 - browse：9324

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Health insurers' Q3 question: how much care are people getting?

WSS

Key House Republican on health care plans exit from Congress

The dental labor crisis is a moment of opportunity

The United States is paying nearly triple for new Covid vaccines

The biotech scorecard for Q4: 16 stock

Congress extends some pandemic preparedness programs

Gilead might be held responsible for not developing a drug

focus

entertainment

focus

Psychedelics group wrestles with new pharma identity

Biogen Alzheimer’s drug launch off to slow start

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Karikó problem: Lessons for funding basic research

Virginia high school admissions case could be legal follow

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

What does generative AI mean for health care? We asked experts

KalVista pill reduced swelling 'attacks' caused by genetic disease

What does generative AI mean for health care? We asked experts

What will Novo Nordisk's VC do with its influx of cash?

Wikipedia

Medicare Advantage proposed rates disappoint insurers

The Readout: Gilead, Bernie Sanders, and other pharma news

To avoid data mishandling cases, universities eye AI and other tools

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Key House Republican on health care plans exit from Congress

CRISPR base editing slashes cholesterol levels in monkeys

Wikipedia

hotspot

knowledge

entertainment